Search Results - Dexamethasone OR corticosteroid

PubPharm (23)

1

Two Fatal Cases of Acute Liver Failure Due to HSV-1 Infection in COVID-19 Patients Following Immunomodulatory Therapies

in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | Vol. 73, No. 1 (2021), p. e252-e255

by Busani, S. | Bedini, A. | Biagioni, E. | +90

2

The landscape of candidemia during the COVID-19 pandemic

in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | (18.06.2021)

by Seagle, E. | Jackson, B. | Lockhart, S. | +17

CommentIn: Clin Infect Dis. 2021 Jul 15;:. - PMID 34265057

3

Immunomodulation as Treatment for Severe Coronavirus Disease 2019 : A Systematic Review of Current Modalities and Future Directions

in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | Vol. 72, No. 12 (2021), p. e1130-e1143

by Meyerowitz, E. | Sen, P. | Schoenfeld, S. | +5

CommentIn: Clin Infect Dis. 2021 Jun 15;72(12):e1144-e1145. - PMID 33285564

4

Improved survival among hospitalized patients with COVID-19 treated with remdesivir and dexamethasone. A nationwide population-based cohort study

in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | (10.06.2021)

by Benfield, T. | Bodilsen, J. | Brieghel, C. | +28

5

Survival Analysis of Treatment Efficacy in Comparative Coronavirus Disease 2019 Studies

in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | Vol. 72, No. 11 (2021), p. e887-e889

by McCaw, Z. | Tian, L. | Kim, D. | +2

6

Trends over time in the risk of adverse outcomes among patients with SARS-CoV-2 infection

in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | (11.05.2021)

by Ioannou, G. | O'Hare, A. | Berry, K. | +7

7

Improving the Outcomes of Immunocompromised Patients with COVID-19

in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | (05.05.2021)

by Haidar, G. | Mellors, J.

8

Early Combination of Tocilizumab and Corticosteroids : An Upgrade in Anti-inflammatory Therapy for Severe Coronavirus Disease (COVID)

in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | Vol. 72, No. 9 (2021), p. 1682-1683

by Martínez-Urbistondo, D. | Costa Segovia, R. | Suárez Del Villar Carrero, R. | +2

9

Methylprednisolone as Adjunctive Therapy for Patients Hospitalized With Coronavirus Disease 2019 (COVID-19; Metcovid) : A Randomized, Double-blind, Phase IIb, Placebo-controlled Trial

in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | Vol. 72, No. 9 (2021), p. e373-e381

by Jeronimo, C. | Farias, M. | Val, F. | +119

CommentIn: Clin Infect Dis. 2021 May 4;72(9):e382-e383. - PMID 32845289

10

Methylprednisolone for Coronavirus Disease 2019 (COVID-19) : Was Benjamin Rush Prescient?

in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | Vol. 72, No. 9 (2021), p. e382-e383

by Lennox, J.

CommentOn: Clin Infect Dis. 2021 May 4;72(9):e373-e381. - PMID 32785710

1
2
3
Next »
[3]